Article Text
Correction
Correction: Current therapeutic developments in atrophic age-related macular degeneration
Statistics from Altmetric.com
Hanus J, Zhao F, Wang S. Current therapeutic developments in atrophic age-related macular degeneration. Br J Ophthalmol 2016;100:122–7. In the first paragraph of the “Lipofuscin and visual cycle inhibitors” section of the paper (p. 124), the authors state “A2E, derived from vitamin E, is a byproduct of the visual cycle and a component of lipofuscin”. This sentence should read: “A2E, derived from vitamin A, is a byproduct of the visual cycle and a component of lipofuscin”.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/